Drug Type Bispecific antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism VEGF inhibitors(Vascular endothelial growth factor inhibitors), complement factor inhibitors(Complement Factor inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Preclinical | China | - | |
Wet age-related macular degeneration | Preclinical | China | - |